AquaBounty Technologies (AQB) Stock Price, News & Analysis

Company Overview

AquaBounty Technologies, Inc. is a biotechnology company focused on aquaculture innovation through the development and commercialization of genetically engineered fish. Its flagship product, AquAdvantage Salmon, is an Atlantic salmon strain enhanced with a growth hormone gene that enables faster growth and more efficient feed conversion compared with conventional farmed salmon. By integrating biotechnology into seafood production, AquaBounty aims to address global protein demand while reducing the environmental footprint associated with marine aquaculture.

Founded in 1991, AquaBounty is headquartered in Maynard, Massachusetts, and operates a state-of-the-art, land-based incubation and grow-out facility in Panama. The company’s research and development activities are conducted under strict regulatory oversight, including approval by the U.S. Food and Drug Administration and Health Canada. These approvals paved the way for the first commercial harvests of AquAdvantage Salmon, positioning the company at the forefront of sustainable aquaculture solutions.

In addition to its Panama facility, AquaBounty engages with stakeholders throughout North America to support supply chain integration and product distribution. The company collaborates with seafood processors, distributors, and retailers to bring its fast-growing salmon to market, emphasizing traceability and quality control in every step. AquaBounty’s approach seeks to balance consumer demand for protein with wider environmental and resource-use considerations.

AquaBounty is led by Dr. Ron Stotish, President and Chief Executive Officer, who has guided the company’s strategic direction and regulatory efforts since joining the executive team. Supported by a board and management team with expertise in biotechnology, aquaculture, and food safety, the company continues to explore additional applications of genetic enhancement in aquaculture species while maintaining a focus on sustainability and regulatory compliance.

Key Stats

• Today's Range: $0.98 to $1.05
• 50-Day Range: $0.86 to $1.12
• 52-Week Range: $0.70 to $2.95
• Volume: 21,257 shs
• Average Volume: 39,820 shs
• Market Capitalization: $5.25 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Sell

AquaBounty Technologies Stock Analysis - MarketRank™

AquaBounty Technologies scored higher than 2% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 0.5 / 5
• Analyst Rating: Sell

Consensus Rating

AquaBounty Technologies has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

Amount of Analyst Coverage

AquaBounty Technologies has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of AquaBounty Technologies is -0.86, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of AquaBounty Technologies is -0.86, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.57% of the float of AquaBounty Technologies has been sold short.

Short Interest Ratio / Days to Cover

AquaBounty Technologies has a short interest ratio ("days to cover") of 1.7, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in AquaBounty Technologies has recently increased by 10.71%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

AquaBounty Technologies does not currently pay a dividend.

Dividend Growth

AquaBounty Technologies does not have a long track record of dividend growth.

News and Social Media

• Score: N/A
• News Sentiment: N/A

Company Ownership

• Score: 0.1 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, AquaBounty Technologies insiders have not sold or bought any company stock.

Percentage Held by Insiders

1.02% of the stock of AquaBounty Technologies is held by insiders.

Percentage Held by Institutions

8.92% of the stock of AquaBounty Technologies is held by institutions.

Company Calendar

• Last Earnings: 5/07/2026
• Today: 6/23/2026
• Next Earnings (Estimated): 8/11/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED - BIOMED/GENE
• Sub-Industry: Recreation
• Current Symbol: NASDAQ:AQB
• CIK: 1603978
• Web: www.aquabounty.com
• Phone: (978) 648-6000
• Fax: N/A
• Employees: 100
• Year Founded: 1991

Profitability

• EPS (Trailing Twelve Months): ($1.19)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$18.49 million
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -54.51%
• Return on Assets: -16.67%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.19
• Quick Ratio: 1.19

Sales & Book Value

• Annual Sales: $2.47 million
• Price / Sales: 2.13
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.49) per share
• Price / Book: -2.08

Miscellaneous

• Outstanding Shares: 5,150,000
• Free Float: 5,095,000
• Market Cap: $5.25 million
• Optionable: No Data
• Beta: 1.39